CIPLA's weekly return of 4.01% outperformed its peers SUNPHARMA and GRASIM, but underperformed DIVISLAB. The stock's volatility of 30.87% was relatively moderate compared to its peers. With a Sharpe Ratio of 0.51, CIPLA's return was decent considering the level of risk taken. The stock's Max Drawdown of -0.6% suggests that it was not overly risky this week.

[Volatility: 30.87%]